Amir Reichman
Vermogen: 76 320 $ op 31-05-2026
Vermogen: 76 320 $ op 31-05-2026
Amir Reichman was the founder of NeuroDerm Ltd. since 2003, holding the title of Chief Engineer & Senior Scientist from 2003 to 2009.
Mr. Reichman is currently the Chief Executive Officer & Director at Scinai Immunotherapeutics Ltd. since 2021.
Former positions include Head-Global Vaccines Engineering Core Technology at GlaxoSmithKline Pharmaceuticals SA (Belgium) from 2017 to 2021 and Head-Global Vaccines Value Chain Management at Novartis Vaccines & Diagnostics, Inc. (North Carolina) from 2011 to 2015.
Education includes an undergraduate degree from Ben-Gurion University of the Negev and an MBA from The Wharton School of the University of Pennsylvania.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 16-06-2026 | 67.540.000 ( 0,34% ) | 76 320 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| BIONDVAX PHARMACEUTICALS LTD | Algemeen Directeur | 02-03-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
GlaxoSmithKline Pharmaceuticals SA (Belgium)
GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals and vaccines | Corporate Officer/Principal | 01-03-2021 |
Novartis Vaccines & Diagnostics, Inc. (North Carolina) | Corporate Officer/Principal | 01-01-2015 |
| NEURODERM LTD | Oprichter | 01-01-2009 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeuroDerm Ltd.
NeuroDerm Ltd. BiotechnologyHealth Technology Develops next-generation drug-device combination solutions for central nervous system disorders | Health Technology |
Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd. Pharmaceuticals: OtherHealth Technology Operates as a biopharmaceutical company that develops, manufactures and commercializes immunomodulation therapies for infectious diseases | Health Technology |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals and vaccines | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Vaccines & Diagnostics, Inc. (North Carolina) |
Kies jouw editie
Alle financiële informatie op nationaal niveau